FXN and Friedreich ataxia: However, the behavioral deficits of the YG8R mouse model are still rather mild, and therefore, by exploiting the unstable nature of the GAA repeat mutation, we are currently developing a larger GAA repeat-based FRDA mouse model with more substantial reduction in FXN expression and a more severe behavioral phenotype that would be beneficial to future drug testing.